Literature DB >> 9927735

A human U2 RNA mutant stalled in 3' end processing is impaired in nuclear import.

Q Huang1, T Pederson.   

Abstract

The biosynthesis of U1, U2, U4 and U5 spliceosomal small nuclear RNAs (snRNAs) involves the nuclear export of precursor molecules extended at their 3' ends, followed by a cytoplasmic phase during which the pre-snRNAs assemble into ribonucleoprotein particles and undergo hypermethylation of their 5' caps and 3' end processing prior to nuclear import. Previous studies have demonstrated that the assembly of pre-snRNAs into ribonucleoprotein particles containing the Sm core proteins is essential for nuclear import in mammalian cells but that 5' cap hypermethylation is not. In the present investigation we have asked whether or not 3' end processing is required for nuclear import of U2 RNA. We designed human pre-U2 RNAs that carried modified 3' tails, and identified one that was stalled (or greatly slowed) in 3' end processing, leading to its accumulation in the cytoplasm of human cells. Nonetheless, this 3' processing arrested pre-U2 RNA molecule was found to undergo cytoplasmic assembly into Sm protein-containing complexes to the same extent as normal pre-U2 RNA. The Sm protein-associated, unprocessed mutant pre-U2 RNA was not observed in the nuclear fraction. Using an assay based on suppression of a genetically blocked SV40 pre-mRNA splicing pathway, we found that the 3' processing deficient U2 RNA was significantly reduced in its ability to rescue splicing, consistent with its impaired nuclear import.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927735      PMCID: PMC148282          DOI: 10.1093/nar/27.4.1025

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  12 in total

Review 1.  The 3' end formation in small RNAs.

Authors:  Karthika Perumal; Ram Reddy
Journal:  Gene Expr       Date:  2002

2.  3'-box-dependent processing of human pre-U1 snRNA requires a combination of RNA and protein co-factors.

Authors:  Patricia Uguen; Shona Murphy
Journal:  Nucleic Acids Res       Date:  2004-06-01       Impact factor: 16.971

3.  3'-End polishing of the kinetoplastid spliced leader RNA is performed by SNIP, a 3'-->5' exonuclease with a Motley assortment of small RNA substrates.

Authors:  Gusti M Zeiner; Robert A Hitchcock; Nancy R Sturm; David A Campbell
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

4.  Live-cell characterization and analysis of a clinical isolate of bovine respiratory syncytial virus, using molecular beacons.

Authors:  Philip Santangelo; Nitin Nitin; Leslie LaConte; Amelia Woolums; Gang Bao
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  The C-terminal domain of coilin interacts with Sm proteins and U snRNPs.

Authors:  Hongzhi Xu; Ramesh S Pillai; Teldja N Azzouz; Karl B Shpargel; Christian Kambach; Michael D Hebert; Daniel Schümperli; A Gregory Matera
Journal:  Chromosoma       Date:  2005-07-08       Impact factor: 4.316

6.  NANOSTRUCTURED PROBES FOR IN VIVO GENE DETECTION.

Authors:  Gang Bao; Phillip Santangelo; Nitin Nitin; Won Jong Rhee
Journal:  Nanomedicine (Chichester)       Date:  2010

7.  5' and 3' end modifications of spliceosomal RNAs in Plasmodium falciparum.

Authors:  Praveen Bawankar; Philip J Shaw; Richa Sardana; Prasad H Babar; Swati Patankar
Journal:  Mol Biol Rep       Date:  2009-08-08       Impact factor: 2.316

8.  The C-terminal domain of pol II and a DRB-sensitive kinase are required for 3' processing of U2 snRNA.

Authors:  Joanne E Medlin; Patricia Uguen; Alice Taylor; David L Bentley; Shona Murphy
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

Review 9.  Fluorescent probes for live-cell RNA detection.

Authors:  Gang Bao; Won Jong Rhee; Andrew Tsourkas
Journal:  Annu Rev Biomed Eng       Date:  2009       Impact factor: 9.590

10.  Role of the C-terminal domain of RNA polymerase II in U2 snRNA transcription and 3' processing.

Authors:  Erica Y Jacobs; Ikuo Ogiwara; Alan M Weiner
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.